Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 105,774 | 66,699 | 99,957 | 125,244 | 78,552 |
| Marketable Securities | 540,821 | 523,364 | 421,705 | 406,881 | 248,240 |
| Receivables | 68,357 | 52,583 | 53,046 | 46,143 | 44,013 |
| Inventories | 65,264 | 64,606 | 64,650 | 68,542 | 66,690 |
| TOTAL | $792,579 | $720,247 | $651,623 | $658,520 | $455,823 |
| Non-Current Assets | |||||
| PPE Net | 153,302 | 144,822 | 136,688 | 125,527 | 113,297 |
| Investments And Advances | 17,966 | 51,024 | 95,459 | 58,019 | 19,191 |
| Intangibles | 192,135 | 194,101 | 196,068 | 198,034 | 200,001 |
| Other Non-Current Assets | 169,851 | 177,355 | 194,675 | 180,169 | 77,799 |
| TOTAL | $533,254 | $567,302 | $622,890 | $561,749 | $410,288 |
| Total Assets | $1,325,833 | $1,287,549 | $1,274,513 | $1,220,269 | $866,111 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,179 | 9,110 | 10,431 | 13,008 | 9,160 |
| Accrued Expenses | 52,163 | 50,239 | 70,974 | 60,403 | 47,684 |
| Other current liabilities | 5,026 | 14,864 | 14,736 | 5,406 | 4,504 |
| TOTAL | $228,693 | $232,084 | $253,328 | $86,272 | $70,583 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 409,972 | 404,647 | 401,497 | 549,307 | 407,380 |
| TOTAL | $409,972 | $404,647 | $401,497 | $549,307 | $407,380 |
| Total Liabilities | $638,665 | $636,731 | $654,825 | $635,579 | $477,963 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,455 | 44,025 | 43,863 | 43,444 | 42,742 |
| Common Shares | 44 | 44 | 44 | 43 | 43 |
| Retained earnings | -224,425 | -243,506 | -253,875 | -268,390 | -398,509 |
| Other shareholders' equity | 181 | 172 | 318 | 847 | 1,490 |
| TOTAL | $687,168 | $650,818 | $619,688 | $584,690 | $388,148 |
| Total Liabilities And Equity | $1,325,833 | $1,287,549 | $1,274,513 | $1,220,269 | $866,111 |